Clinical Guidelines & Documents

Authored and endorsed clinical documents provide three main components vital to advancements in the heart rhythm field: analysis, discussion of current issues, and suggestions for clinical application. 

The Society approved the scope for the following new documents and a focused update that are currently under development:

  1. 2019 HRS Expert Consensus Statement on Evaluation and Management of Arrhythmic Risk in Neuromuscular Disorders 
  2. 2019  HRS/EHRA/APHRS/LAHRS Focused Update to 2015 HRS/EHRA/APHRS/SOLAECE Expert Consensus Statement on Optimal Implantable Cardioverter Defibrillator Programming and Testing (Appendix B)
  3. 2020 HRS Expert Consensus Statement on the Management of Arrhythmias During Pregnancy
HRS is partnering with Guideline Central to create pocket cards at a discount to HRS members. Visit www.guidelinecentral.com  to learn more about HRS titles in circulation and how you can access this content in print and on your mobile device.
 

Please email clinicaldocs@hrsonline.org  should you have questions or need further information.

License clinical documents: Complete our license form and submit to Tonia Jones at tjones@hrsonline.org if you are interested in licensing our clinical document content (e.g., clinician summary, slide sets, etc.).

Volunteer with clinical documents: Contact us at clinicaldocs@hrsonline.org  if you are interested in serving as a peer reviewer or writing group member for future clinical documents. Please include your areas of expertise and CV.

Featured Clinical Documents

37909 2019 HRS/EHRA/APHRS/LAHRS Focused Update to 2015 Expert Consensus Statement on Optimal Implantable Cardioverter-Defibrillator Programming and Testing

May 15, 2019—Developed in partnership with and endorsed by the European Heart Rhythm Association, the Asia Pacific Heart Rhythm Society, and the Latin American Heart Rhythm Society, the focused update (centered on Appendix B) relates to the updated manufacturer-specific programming settings/choices based on a compilation of clinical expertise and clinical trial data as reported in the 2015 HRS/EHRA/APHRS/SOLAECE Expert Consensus Statement on Optimal Implantable Cardioverter-Defibrillator Programming and Testing of which Appendix B is a part. These recommended settings/choices represent a diligent effort on the part of the writing committee to translate the consensus statement recommendations to device settings/choices for the specified clinical issues/ICD therapies where the writing committee considered that there was sufficient consensus and supporting data to make recommendations intended to improve the safety, morbidity, and mortality profile of patients with these clinical issues/ICD therapies.

Download the PDF 187.64 kB

37820 2019 HRS/EHRA/APHRS/LAHRS Expert Consensus Statement on Catheter Ablation of Ventricular Arrhythmias

May 10, 2019—The consensus statement, accompanied by a systematic review and meta-analysis published in conjunction with this document, serves as a resource guide and comprehensive review of the field for clinicians around the world who are working to improve the care of patients undergoing ablation for ventricular arrhythmias. It relates to ablation therapy for ventricular arrhythmias, from premature ventricular complexes to monomorphic and polymorphic ventricular tachycardia, and triggers of ventricular fibrillation, and delves into detail on the indications and technical aspects of ventricular arrhythmia ablation. It offers guidance on how to select patients for catheter ablation, perform procedures in a safe and efficacious manner, and provide follow-up and adjunctive care to obtain the best possible outcomes for patients with ventricular arrhythmias.

The document features a pocket guide, developed in partnership with Guideline Central and available across multiple platforms, including print, electronic media, and the Guideline Central mobile app. Visit www.guidelinecentral.com to access the pocket guide.
Download the PDF 3.50 MB

37811 2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy

May 9, 2019—The expert consensus statement defines the broader condition of arrhythmogenic cardiomyopathy (ACM) that incorporates a spectrum of genetic, systematic, infectious, and inflammatory disorders. The designation includes, but is not limited to, arrhythmogenic right/left ventricular cardiomyopathy, ion channel abnormalities, amyloidosis, and left ventricular noncompaction. The consensus statement provides the clinician with guidance on evaluation and management of ACM and includes clinically relevant information on genetics and disease mechanisms. PICO (Patient, Intervention, Comparison, Outcome) questions were utilized to evaluate contemporary evidence and provide clinical guidance related to exercise in arrhythmogenic right ventricular cardiomyopathy.

The document features a pocket guide, developed in partnership with Guideline Central and available across multiple platforms, including print, electronic media, and the Guideline Central mobile app. Visit www.guidelinecentral.com  to access the pocket guide.
Download the PDF 6.26 MB

37764 HRS White Paper on Interoperability of Data from Cardiovascular Implantable Electronic Devices

May 8, 2019—This document provides a brief overview of U.S. federal initiatives to promote interoperability of data, the requirements needed to communicate data between information technology systems in a way that permits the sending and receiving systems to understand and process the data, a summary of the work of HRS to date, and finally strategies for clinicians seeking an environment in which they can manage their cardiovascular implantable electronic device (CIED) patient data in a single IT system.

Download the PDF 1.11 MB

37761 Transparent Sharing of Digital Health Data: A Call to Action

May 8, 2019—Heart rhythm care professionals and patients routinely depend upon digital health data obtained by cardiovascular implantable electronic devices, medical-grade ambulatory cardiac monitors, and most recently consumer personal biometric monitoring devices. Yet the data typically reside either exclusively with the health care team, or, in the case of consumer devices, with the patient. If we are to realize the transformative opportunity of digital health, it will be necessary to ensure that all stakeholders, particularly patients, have complete, transparent, and secure access to their data. This document (accompanied by an editorial “Digital Health: Present Conundrum, Future Hope or Hype? ”) focuses on digital health and cardiac electrophysiology, outlining the present state and future vision of key stakeholder groups. It also is meant to serve as a call to action to heart rhythm professionals to join in leading this transformation.

Download the PDF 517.91 kB